N
TMDX icon

Natixis’s Transmedics TMDX Stock Holding History

Natixis’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11,786
Closed -$1.78M – 1108
2024
Q2 		$1.78M Sell
11,786
-7,287
-38% -$874K 0.01% 432
2024
Q1 		$1.41M Sell
19,073
-4,972
-21% -$410K 0.01% 476
2023
Q4 		$1.9M Sell
24,045
-5,712
-19% -$345K 0.01% 422
2023
Q3 		$1.63M Sell
29,757
-4,725
-14% -$340K 0.01% 426
2023
Q2 		$2.9M Sell
34,482
-196
-0.6% -$15K 0.02% 368
2023
Q1 		$2.63M Sell
34,678
-36,710
-51% -$2.54M 0.02% 369
2022
Q4 		$4.41M Buy
71,388
+34,392
+93% +$1.83M 0.02% 399
2022
Q3 		$1.62M Buy
36,996
+8,676
+31% +$377K 0.01% 660
2022
Q2 		$860K Buy
+28,320
New +$755K ﹤0.01% 853

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Natixis's TMDX Position: Q3 2024 in Review

Natixis sold out of Transmedics (TMDX) in Q3 2024, closing a stake of 11,786 shares — an estimated $1.78M sold.

Natixis first reported a position in TMDX in Q2 2022 and held it in 9 quarters. The position peaked at $4.41M in Q4 2022. 373 funds tracked by Wall St. Rank hold TMDX as of Q3 2024.

  • Natixis reported no remaining Transmedics position as of Q3 2024 after selling out during the quarter.
  • Natixis sold 11,786 Transmedics shares in Q3 2024, an estimated $1.78M.
  • Natixis first reported a position in Transmedics in Q2 2022 and held it in 9 quarters.
  • Natixis's Transmedics position peaked at $4.41M in Q4 2022.
  • 373 funds tracked by Wall St. Rank held Transmedics as of Q3 2024.

Based on Natixis's 13F filing for Q3 2024, filed 13 Nov 2024.